Stuart L Solomon

Author PubWeight™ 3.56^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	A randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial.	J Am Coll Cardiol	2010	1.80
2	Late safety, efficacy, and cost-effectiveness of a zotarolimus-eluting stent compared with a paclitaxel-eluting stent in patients with de novo coronary lesions: 2-year follow-up from the ENDEAVOR IV trial (Randomized, Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Taxus Paclitaxel-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions).	JACC Cardiovasc Interv	2009	1.11
3	Initial experience with a magnetic navigation system for percutaneous coronary intervention in complex coronary artery lesions.	J Am Coll Cardiol	2006	0.85
4	Initial impact of drug-eluting stent use on the spectrum of patients undergoing percutaneous coronary intervention.	Coron Artery Dis	2006	0.75